Citigroup Issues Positive Forecast for DexCom (NASDAQ:DXCM) Stock Price
DexCom (NASDAQ:DXCM – Get Free Report) had its price target increased by equities researchers at Citigroup from $101.00 to $104.00 in a note issued to investors on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the medical device company’s stock. Citigroup’s price target would indicate a potential upside of 26.89% from the company’s […]
DexCom (NASDAQ:DXCM – Get Free Report) had its price target increased by equities researchers at Citigroup from $101.00 to $104.00 in a note issued to investors on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the medical device company’s stock. Citigroup’s price target would indicate a potential upside of 26.89% from the company’s […]
